Personalized medicine is a promising treatment for recurrent cancer and superbugs, but it is labour-intensive and expensive, and pathways for its regulatory approval and reimbursement are complicated.
Academic rigor, journalistic flair
Articles on Phage therapy
Displaying all articles
We tend to just think of viruses in terms of their damaging impacts on human health and lives. But viruses can also be used to benefit human health, agriculture and the environment.
Researchers are desperately seeking viable alternatives to antibiotics. So what is phage therapy? And how could it help?
Viruses have gotten a bad rap for the many illnesses and pandemics they’ve caused. But viruses are also genetic innovators – and possibly the pioneers of using DNA as the genetic blueprint of life.
We found a new way to revert antibiotic resistance. It involves using phage therapy to resensitise a type of bacteria to antibiotics.
The CDC just released a list of bacteria and fungi that pose, or have the potential to pose, a serious health threat. Here are four strategies for curbing the rise of these superbugs.
Bacteria are becoming resistant to even the most powerful antibiotics. These expensive, hard-to-treat infections are prompting physicians to reassess using viruses to destroy bacteria.
The virus that could cure antibiotic resistant infections.
Bacterial infections remain a major threat to human and animal health. Worse still, the catalogue of useful antibiotics is shrinking as pathogens build up resistance to these drugs. There are few promising…
The introduction into clinical practice of antibiotics is arguably the most significant medical advance of the 20th century. Together with immunisation and better public sanitation, they’ve had a significant…
Bacteria-eating viruses that kill the hospital superbug C. difficile have been isolated by scientists. The use of these kinds of viruses, known as phages, to tackle bacterial infection was employed before…
Top contributors
-
Postdoctoral Fellow, EPFL – École Polytechnique Fédérale de Lausanne – Swiss Federal Institute of Technology in Lausanne
-
Professor of Microbiology, UCL
-
Lecturer in Evolutionary Biology, University of York
-
Professor of Molecular Microbiology, UCL
-
Johann Friedrich Miescher Regents Professor in Molecular Biology, The University of Texas at Austin
-
Reader in Biology, University of Leicester
-
Postdoctoral Researcher, Monash University
-
Senior Lecturer in School of Biological Sciences, Microbiology, Monash University
-
Professor of Biological Sciences, University of Maryland, Baltimore County
-
Visiting Scientist, The Rockefeller University
-
Senior Research Fellow, School of Medicine, The University of Western Australia
-
Associate Director of Microbiology, University of California, San Diego
-
NHMRC Emerging Leadership Fellow, The University of Western Australia
-
Professor, Nursing, School of Nursing and Midwifery, Griffith University
-
Professor of Biocchemistry and Biomedical Sciences, McMaster University
